AI Medical Compendium Topic

Explore the latest research on artificial intelligence and machine learning in medicine.

Drug Design

Showing 171 to 180 of 538 articles

Clear Filters

Generative deep learning enables the discovery of a potent and selective RIPK1 inhibitor.

Nature communications
The retrieval of hit/lead compounds with novel scaffolds during early drug development is an important but challenging task. Various generative models have been proposed to create drug-like molecules. However, the capacity of these generative models ...

A New Hybrid Neural Network Deep Learning Method for Protein-Ligand Binding Affinity Prediction and De Novo Drug Design.

International journal of molecular sciences
Accurately predicting ligand binding affinity in a virtual screening campaign is still challenging. Here, we developed hybrid neural network (HNN) machine deep learning methods, HNN-denovo and HNN-affinity, by combining the 3D-CNN (convolutional neur...

Systems Drug Design for Muscle Invasive Bladder Cancer and Advanced Bladder Cancer by Genome-Wide Microarray Data and Deep Learning Method with Drug Design Specifications.

International journal of molecular sciences
Bladder cancer is the 10th most common cancer worldwide. Due to the lack of understanding of the oncogenic mechanisms between muscle-invasive bladder cancer (MIBC) and advanced bladder cancer (ABC) and the limitations of current treatments, novel the...

CADD, AI and ML in drug discovery: A comprehensive review.

European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences
Computer-aided drug design (CADD) is an emerging field that has drawn a lot of interest because of its potential to expedite and lower the cost of the drug development process. Drug discovery research is expensive and time-consuming, and it frequentl...

Selective Inhibitor Design for Kinase Homologs Using Multiobjective Monte Carlo Tree Search.

Journal of chemical information and modeling
Designing highly selective molecules for a drug target protein is a challenging task in drug discovery. This task can be regarded as a multiobjective problem that simultaneously satisfies criteria for various objectives, such as selectivity for a tar...

Application of Computational Biology and Artificial Intelligence in Drug Design.

International journal of molecular sciences
Traditional drug design requires a great amount of research time and developmental expense. Booming computational approaches, including computational biology, computer-aided drug design, and artificial intelligence, have the potential to expedite the...

Training recurrent neural networks as generative neural networks for molecular structures: how does it impact drug discovery?

Expert opinion on drug discovery
INTRODUCTION: Deep learning approaches have become popular in recent years in de novo drug design. Generative models for molecule generation and optimization have shown promising results. Molecules trained on different chemical data could regenerate ...

De novo design of anti-tuberculosis agents using a structure-based deep learning method.

Journal of molecular graphics & modelling
Mycobacterium tuberculosis (Mtb) is a pathogen of major concern due to its ability to withstand both first- and second-line antibiotics, leading to drug resistance. Thus, there is a critical need for identification of novel anti-tuberculosis agents t...

Adversarial deep evolutionary learning for drug design.

Bio Systems
The design of a new therapeutic agent is a time-consuming and expensive process. The rise of machine intelligence provides a grand opportunity of expeditiously discovering novel drug candidates through smart search in the vast molecular structural sp...

Drug Design Using Reinforcement Learning with Graph-Based Deep Generative Models.

Journal of chemical information and modeling
Machine learning provides effective computational tools for exploring the chemical space via deep generative models. Here, we propose a new reinforcement learning scheme to fine-tune graph-based deep generative models for molecular design tasks. We ...